WU
16
2
SO
64
-2
ABBV
51
-2
NRG
57
2
CA
36
-4
NUE
50
3
AIZ
71
-2
MNST
52
2
BLK
69
2
TJX
50
2
CCI
36
-5
TDC
47
-2
BWA
42
-2
IFF
60
-3
WYNN
34
-3
O
35
-2
UNP
48
-2
MCK
46
-3
D
55
-6
VFC
57
4
WU
16
2
SO
64
-2
ABBV
51
-2
NRG
57
2
CA
36
-4
NUE
50
3
AIZ
71
-2
MNST
52
2
BLK
69
2
TJX
50
2
CCI
36
-5
TDC
47
-2
BWA
42
-2
IFF
60
-3
WYNN
34
-3
O
35
-2
UNP
48
-2
MCK
46
-3
D
55
-6
VFC
57
4
Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Corcept Therapeutics Industry Stock Comparison

Sell
41

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
14.28
Seasonality Move:
-4.75%
Buy
68

CORT
Corcept Therapeutics

Last Price:
40.92
Seasonality Move:
-0.77%
Sell
41
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.58. The Score for BIS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy, Sell or Hold?

  • The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $14.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

  • The Corcept Therapeutics share price today is $42.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 43.63 Sell
Chaikin Money Flow: 4619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.4 - 15.18) Sell
Bollinger Bands (100): (14.77 - 17.73) Sell

CORT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.36 Buy
Relative Strength Index (14 RSI): 82.3 Buy
Chaikin Money Flow: 670376 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.47 - 37.45) Buy
Bollinger Bands (100): (28.16 - 35.86) Buy

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.74 Sell
20-day SMA: 14.73 Sell
50-day SMA: 14.98 Sell
200-day SMA: 17.4 Sell
8-day EMA: 14.67 Sell
20-day EMA: 14.82 Sell
50-day EMA: 15.25 Sell
200-day EMA: 17.33 Sell

CORT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.44 Buy
20-day SMA: 35.75 Buy
50-day SMA: 34.88 Buy
200-day SMA: 28.43 Buy
8-day EMA: 38.24 Buy
20-day EMA: 36.43 Buy
50-day EMA: 34.68 Buy
200-day EMA: 30.05 Buy

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):